Positioning political selling, disclosed 2026-09-24
Options put/call open interest 0.41, read 2026-10-31
Ethical passes the values gate
Price614.99 USD
Fair value816.47
Ethical score82.0/100
RatingOPPORTUNITY
Our investment reviews on this name
2026-10-21Read Distribution736.72-16.5% to today ✓Markup gives way to Distribution after a 14% rise in 13 weeks
2026-07-22Read Markup646.01-4.8% to today Distribution gives way to Markup after a 9% rise in 3 weeks
2026-07-02Read Distribution593.00+3.7% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Every chart read we post on this name lands here. Each one says which way we lean, how firmly, and the line that would prove us wrong. When price settles a read, we add a new entry and say plainly how it went.
Entries are point-in-time and never edited. Times in UTC. Not advice.
25 Oct03:47 UTC
ReadDaily chartOpen
↔
Sideways · slight
Wrong if two daily closes land outside 681.05 to 771.27.
Box681 to 771
Ceiling area713
Meta is messy on the daily. It keeps running into the 713 area and has slipped under 681, while the weekly is still rising. When the picture is this mixed I stand aside. Two daily closes back inside 681 to 771 or a clean break either way will tell me more. Not advice.
Chart as posted, 25 Oct 03:47 UTC. Daily candles to the 23 Oct close.
A read stays open until price settles it. Held and Hit mean the line we named did its job. Wrong means it did not. Grey means nothing triggered.
Also posted on our social channels.
The full research record, in depth, below
The Label · The Season, Not the Day
This name holds its distribution label.
Meta Platforms holds its Distribution at $614.99. The statistical read favours the sellers, held for 24 days.
As held on the ledger · 2026-10-30
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 24 days
Price at the screen
$614.99
Valuation
21.31 trailing · 17.55 forward price to earnings
Values screen
PASS· score 82.0
Beta
1.19
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
22.92%
Below 33%
Interest-bearing debt is just 22.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
7.52%
Below 33%
Cash held in interest-bearing accounts and securities is 7.5% of assets, under the one-third limit.
Pass
Receivables
15.20%
Below 49%
Money owed to the company is 15.2% of assets, under the 49% limit.
Pass
Revenue purity
1.06%
Below 5%
Only 1.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Meta Platforms clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 23%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-10-31. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when META's ethical verdict changes
Today META passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · BDS Movement, Employee campaigns
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited by BDS movement for content moderation policies alleged to suppress Palestinian voices, and for major R&D operations in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads OPPORTUNITY: it trades at roughly a 33% discount to our $816.47 fair value, strong competitive moat, 26.10% revenue growth.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 32.8% margin of safety to the base estimate.
Third-party analyst targets: 58 covering, consensus Strong Buy. The average target sits +38% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Social Giant Meta, Undervalued and Ethical
Imagine the world's largest digital gathering place, where over 3 billion people come to connect, share, and find community - that's Meta Platforms in a nutshell. With a footprint spanning mobile devices, personal computers, and the cutting edge of virtual reality headsets and AI glasses, Meta's influence is hard to overstate.
Why it stands out is not just its vast reach but its financials and valuation. Revenues are growing at a robust 28%, profit margins sit at an impressive 30%, and its return on equity is a stellar 30%. The market is currently pricing META at a forward P/E of 15.7x, significantly below our fair value of $756.75, indicating a substantial margin of safety of +39%. With 57 analysts rating it a strong buy and a consensus target of $750, the market agrees.
Risk does exist, primarily in the form of regulatory scrutiny and the ever-evolving digital landscape. However, Meta has passed our ethical screen, demonstrating a commitment to responsible business practices alongside its financial prowess. Given its strong moat and the current market conditions, Meta presents a compelling opportunity for ethically-minded investors.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
META trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Distribution$736.72+0.0%Entry 22
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markup$736.72+0.0%Entry 20
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markup$736.72+0.0%Entry 19
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$736.72+0.0%Entry 18
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markup$736.72+0.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markup$736.72-0.1%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markup$737.54+2.6%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markup$718.67-4.4%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markup$751.66+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 18%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (58 analysts) rates it strong buy, with a mean price target of $827. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
